Open access · CC-BY
via OpenAlex
The microbial metabolite urolithin A reduces Clostridioides difficile toxin expression and toxin-induced epithelial damage
Sweta Ghosh, Daniel Erickson, Michelle J. Chua, James Collins, Venkatakrishna Rao Jala
mSystems · 2024 · ▲ 24 citations
Dysbiosis
Stem-cell exhaustion
Chronic inflammation
Microbiome / FMT
Human
Mouse
Preclinical / animal
Abstract
Therapy for Clostridioides difficile infections includes the use of antibiotics, immunosuppressors, and fecal microbiota transplantation. However, these treatments have several drawbacks, including the loss of colonization resistance, the promotion of autoimmune disorders, and the potential for unknown pathogens in donor samples. To date, the potential benefits of microbial metabolites in CDI-induced colitis have not been fully investigated. Here, we report for the first time that the microbial metabolite urolithin A has the potential to block toxin production from C. difficile and enhance gut barrier function to mitigate CDI-induced colitis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1128/msystems.01255-23
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Ghosh, S., Erickson, D., Chua, M.J., Collins, J., & Jala, V.R. (2024). The microbial metabolite urolithin A reduces Clostridioides difficile toxin expression and toxin-induced epithelial damage. <em>mSystems</em>. https://doi.org/10.1128/msystems.01255-23
Vancouver
Ghosh S, Erickson D, Chua MJ, Collins J, Jala VR. The microbial metabolite urolithin A reduces Clostridioides difficile toxin expression and toxin-induced epithelial damage. mSystems. 2024. doi:10.1128/msystems.01255-23.
BibTeX
@article{sweta2024Themic,
title = {The microbial metabolite urolithin A reduces Clostridioides difficile toxin expression and toxin-induced epithelial damage},
author = {Sweta Ghosh and Daniel Erickson and Michelle J. Chua and James Collins and Venkatakrishna Rao Jala},
journal = {mSystems},
year = {2024},
doi = {10.1128/msystems.01255-23},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2023
Preprint · CC-BY
The microbial metabolite Urolithin A reduces C. difficile toxin expression and repairs toxin-induced epithelial damage
Frontiers in Medicine 2022
Open access · CC-BY
Gut Dysbiosis and Kidney Diseases
Nutrients 2021
Open access · CC-BY
Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer’s Disease
Nature Communications 2019
Open access · CC-BY
Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway
Ageing Research Reviews 2026
Open access · CC-BY
Age-related sarcopenia and the gut microbiome: mechanistic insights into the gut-muscle axis and potential microbiome based therapeutic interventions
Neural Regeneration Research 2024
Open access · CC-BY